NEWS

Cerus Endovascular Receives CE Mark Approval for its Contour Neurovascul...

FREMONT, Calif. and OXFORD, England - Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its lead product, the Contour Neurovascular System™, for the treatment of intracranial aneurysms.

Thrombectomy - ADAPT with Snake bite technique

Cascade Net – an innovative non-occlusive remodeling device for temporar...

Multi-center clinical experience in 15 cases with the innovative CE-marked Cascade Net device was highlighted in the January 2020 Journal of Neurosurgery article, “Early experience with a novel net temporary bridging device (Cascade) to assist endovascular coil embolization of intracranial aneurysms” by Dr Alejandro Tomasello et al*.

Cascade Net – a non-occlusive remodeling device

Ascending pharyngeal with its “dangerous” anastomoses

YouTube Contest - Win your ticket to the LINNC!

Glue-cast pressure cooker technique with venous balloon

Sensome raises $9 million B round with equity investment from Asahi Intecc

The two companies start development program to integrate Sensome’s tissue micro-sensor into Asahi’s world class guidewire

MicroVention Announces FDA Premarket Approval of a New Flow Diverter for...

Aliso Viejo, CA. – January 9, 2020 – MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.  

Medtronic Receives CE Mark Approval for the Percept™ PC Neurostimulator...

This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients